As the maritime industry faces increasing operational pressure, growing compliance demands, crew wellbeing challenges, and the need for more proactive health management, Health4Crew and DNAlogy are pleased to announce a strategic collaboration focused on advancing preventive healthcare and innovative drug & alcohol screening services within the global shipping industry. The collaboration combines Health4Crew’s rapidly growing maritime telemedicine and digital health platform with DNAlogy’s expertise in toxicology testing, certified screening procedures, and advanced drug & alcohol testing solutions.
Together, the two companies aim to support shipping companies with a more integrated, proactive, and data-driven approach to crew health, compliance, and operational safety. The collaboration places a strong focus on the human element at sea, as both companies recognize the challenges every seafarer faces, especially during these turbulent times. As shipping continues its digital transformation journey, both companies believe the future of maritime operations will increasingly rely on integrated health, safety, and compliance ecosystems.
Under the agreement, Health4Crew will integrate DNAlogy’s certified drug and alcohol testing into its telemedicine platform, giving shipping companies a single workflow.
A Shared Vision for a Safer and Healthier Maritime Industry
At the heart of the collaboration lies a common belief: healthier crews create safer and more efficient vessels. The collaboration between Health4Crew and DNAlogy aims to provide shipping companies with:
- Enhanced crew health monitoring
- Preventive healthcare services
- Drug & alcohol screening support
- Improved compliance procedures
- Faster medical response and reporting
- Greater operational transparency and safety culture
“Innovation means little if it does not improve the everyday lives, wellbeing, and safety of seafarers and at the same time if all the data is not provided in an integrated and concise manner…” said Mrs Agathi Natsi, Co-founder and CEO of Health4Crew. She continued: “We believe digital healthcare and preventive screening solutions must work together to support both the crew and the shipping company in a practical, efficient, and human-centric manner.”
Dr George Fitsialos, Founder and CEO of DNAlogy added: “The maritime industry operates in one of the most demanding environments in the world. Reliable, modern and transparent testing procedures, combined with proactive healthcare support, play a major role in reducing risks and strengthening operational safety.”
